105 related articles for article (PubMed ID: 7531843)
21. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor.
Valentino RJ; Page ME; Curtis AL
Brain Res; 1991 Jul; 555(1):25-34. PubMed ID: 1933327
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of galanin binding sites and GalR1 mRNA levels in the mouse locus coeruleus following chronic morphine treatments and precipitated morphine withdrawal.
Zachariou V; Thome J; Parikh K; Picciotto MR
Neuropsychopharmacology; 2000 Aug; 23(2):127-37. PubMed ID: 10882839
[TBL] [Abstract][Full Text] [Related]
23. Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration.
Rasmussen K; Krystal JH; Aghajanian GK
Psychopharmacology (Berl); 1991; 105(4):508-12. PubMed ID: 1771218
[TBL] [Abstract][Full Text] [Related]
24. Local opiate withdrawal in locus coeruleus neurons in vitro.
Ivanov A; Aston-Jones G
J Neurophysiol; 2001 Jun; 85(6):2388-97. PubMed ID: 11387385
[TBL] [Abstract][Full Text] [Related]
25. Activation of locus coeruleus somatostatin receptors induces an increase of growth hormone release in male rats.
Mounier F; Bluet-Pajot MT; Moinard F; Kordon C; Epelbaum J
J Neuroendocrinol; 1996 Oct; 8(10):761-4. PubMed ID: 8910805
[TBL] [Abstract][Full Text] [Related]
26. Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus.
Medrano MC; Mendiguren A; Pineda J
Psychopharmacology (Berl); 2015 Aug; 232(15):2795-809. PubMed ID: 25787747
[TBL] [Abstract][Full Text] [Related]
27. Attenuation of withdrawal-induced hyperactivity of locus coeruleus neurones by inhibitors of nitric oxide synthase in morphine-dependent rats.
Pineda J; Torrecilla M; Martín-Ruiz R; Ugedo L
Neuropharmacology; 1998 Jun; 37(6):759-67. PubMed ID: 9707290
[TBL] [Abstract][Full Text] [Related]
28. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus.
Valentino RJ; Foote SL; Aston-Jones G
Brain Res; 1983 Jul; 270(2):363-7. PubMed ID: 6603889
[TBL] [Abstract][Full Text] [Related]
29. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.
Rasmussen K; Fuller RW; Stockton ME; Perry KW; Swinford RM; Ornstein PL
Eur J Pharmacol; 1991 May; 197(1):9-16. PubMed ID: 1832640
[TBL] [Abstract][Full Text] [Related]
30. The CRF1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats.
Lejeune F; Millan MJ
Eur J Pharmacol; 2003 Mar; 464(2-3):127-33. PubMed ID: 12620504
[TBL] [Abstract][Full Text] [Related]
31. Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats.
Swiergiel AH; Takahashi LK; Rubin WW; Kalin NH
Brain Res; 1992 Aug; 587(2):263-8. PubMed ID: 1326376
[TBL] [Abstract][Full Text] [Related]
32. Locus coeruleus galanin expression is enhanced after exercise in rats selectively bred for high capacity for aerobic activity.
Murray PS; Groves JL; Pettett BJ; Britton SL; Koch LG; Dishman RK; Holmes PV
Peptides; 2010 Dec; 31(12):2264-8. PubMed ID: 20850488
[TBL] [Abstract][Full Text] [Related]
33. Possible involvement of the locus coeruleus in inhibition by prostanoid EP(3) receptor-selective agonists of morphine withdrawal syndrome in rats.
Nakagawa T; Masuda T; Watanabe T; Minami M; Satoh M
Eur J Pharmacol; 2000 Mar; 390(3):257-66. PubMed ID: 10708732
[TBL] [Abstract][Full Text] [Related]
34. Infusion of adrenergic receptor agonists and antagonists into the locus coeruleus and ventricular system of the brain. Effects on swim-motivated and spontaneous motor activity.
Weiss JM; Simson PG; Hoffman LJ; Ambrose MJ; Cooper S; Webster A
Neuropharmacology; 1986 Apr; 25(4):367-84. PubMed ID: 2872608
[TBL] [Abstract][Full Text] [Related]
35. Effects of pretreatment with corticotropin-releasing factor on the electrophysiological responsivity of the locus coeruleus to subsequent corticotropin-releasing factor challenge.
Conti LH; Foote SL
Neuroscience; 1995 Nov; 69(1):209-19. PubMed ID: 8637619
[TBL] [Abstract][Full Text] [Related]
36. Influence of corticotropin-releasing hormone on electrophysiological activity of locus coeruleus neurons.
Borsody MK; Weiss JM
Brain Res; 1996 Jun; 724(2):149-68. PubMed ID: 8828564
[TBL] [Abstract][Full Text] [Related]
37. Nimodipine reduction of naltrexone-precipitated locus coeruleus activation and abstinence behavior in morphine-dependent rats.
Krystal JH; Compere S; Nestler EJ; Rasmussen K
Physiol Behav; 1996; 59(4-5):863-6. PubMed ID: 8778878
[TBL] [Abstract][Full Text] [Related]
38. Locus coeruleus neurons from morphine-treated rats do not show opiate-withdrawal hyperactivity in vitro.
Bell JA; Grant SJ
Brain Res; 1998 Mar; 788(1-2):237-44. PubMed ID: 9555033
[TBL] [Abstract][Full Text] [Related]
39. Activation of brain noradrenergic neurons during recovery from halothane anesthesia. Persistence of phasic activation after clonidine.
Saunier CF; Akaoka H; de La Chapelle B; Charléty PJ; Chergui K; Chouvet G; Buda M; Quintin L
Anesthesiology; 1993 Nov; 79(5):1072-82. PubMed ID: 8238984
[TBL] [Abstract][Full Text] [Related]
40. Electrocortical power spectrum changes induced by microinfusion of corticotropin-releasing factor into the locus coeruleus in rats.
De Sarro GB; Fratta W; Giglio A; Nisticò G
Funct Neurol; 1992; 7(5):407-12. PubMed ID: 1292962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
